Literature DB >> 16432018

Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication.

Shuanghu Liu1, Israrul H Ansari1, Subash C Das1, Asit K Pattnaik1.   

Abstract

Hepatitis C virus (HCV) non-structural protein 5A (NS5A) plays an essential role in viral genome replication. A series of transposon-mediated insertion mutants and deletion mutants of NS5A was used to examine the colony-forming ability of HCV subgenomic replicons encoding the mutant proteins. The results reveal that two regions of NS5A can tolerate insertions: one spanning residues 240-314, which contain the interferon sensitivity-determining region (ISDR), and the other spanning residues 349-417 at the carboxy terminus. The majority of these sites also tolerated insertion of enhanced green fluorescent protein. Furthermore, replicons encoding NS5A with deletions in ISDR or in the carboxy-terminal regions were replication-competent, indicating that these regions of NS5A are not necessary for replication. Taken together, the results suggest that the central region spanning the ISDR and the carboxy-terminal region of the molecule are dispensable for the functions of NS5A in viral genome replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432018     DOI: 10.1099/vir.0.81407-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.

Authors:  Shuanghu Liu; Cassie A Nelson; Li Xiao; Ling Lu; Punit P Seth; Darrell R Davis; Curt H Hagedorn
Journal:  Antiviral Res       Date:  2010-11-12       Impact factor: 5.970

2.  Identification of tolerated insertion sites in poliovirus non-structural proteins.

Authors:  Natalya L Teterina; Chris Lauber; Kenneth S Jensen; Eric A Levenson; Alexander E Gorbalenya; Ellie Ehrenfeld
Journal:  Virology       Date:  2010-10-23       Impact factor: 3.616

Review 3.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

4.  Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system.

Authors:  Robert A Fridell; Dike Qiu; Chunfu Wang; Lourdes Valera; Min Gao
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

5.  Functional characterization of bovine viral diarrhea virus nonstructural protein 5A by reverse genetic analysis and live cell imaging.

Authors:  Olaf Isken; Ulrike Langerwisch; Robert Schönherr; Benjamin Lamp; Kristin Schröder; Rainer Duden; Tillmann H Rümenapf; Norbert Tautz
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

6.  Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.

Authors:  Judith M Gottwein; Tanja B Jensen; Christian K Mathiesen; Philip Meuleman; Stephanie B N Serre; Jacob B Lademann; Lubna Ghanem; Troels K H Scheel; Geert Leroux-Roels; Jens Bukh
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

7.  The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India.

Authors:  Ankur Goyal; Wolf P Hofmann; Eva Hermann; Stella Traver; Syed S Hissar; Naveen Arora; Hubert E Blum; Stefan Zeuzem; Christoph Sarrazin; Shiv K Sarin
Journal:  Med Microbiol Immunol       Date:  2006-09-06       Impact factor: 3.402

8.  A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.

Authors:  Shuanghu Liu; Li Xiao; Cassie Nelson; Curt H Hagedorn; Curt Hagedorn
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

9.  Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein.

Authors:  Timothy L Tellinghuisen; Katie L Foss; Jason C Treadaway; Charles M Rice
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

10.  Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.

Authors:  Pascal Veillon; Christopher Payan; Hélène Le Guillou-Guillemette; Catherine Gaudy; Françoise Lunel
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.